Literature DB >> 30145689

The psychological slippery slope from physician-assisted death to active euthanasia: a paragon of fallacious reasoning.

Jordan Potter1.   

Abstract

In the debate surrounding the morality and legality of the practices of physician-assisted death and euthanasia, a common logical argument regularly employed against these practices is the "slippery slope argument." One formulation of this argument claims that acceptance of physician-assisted death will eventually lead down a "slippery slope" into acceptance of active euthanasia, including its voluntary, non-voluntary, and/or involuntary forms, through psychological and social processes that warp a society's values and moral perspective of a practice over an extended period of time. This formulation is known as the psychological slippery slope argument. This paper analyzes the psychological slippery slope argument as it is applied to the practice of physician-assisted death, and utilizing recent empirical evidence from various nations around the world that practice physician-assisted death and/or euthanasia, the paper argues that (1) employing the psychological slippery slope argument against physician-assisted death is logically fallacious, (2) this kind of slippery slope is unfounded in practice, and thus (3) the psychological slippery slope argument is insufficient on its own to justify continued legal prohibition of physician-assisted death.

Entities:  

Keywords:  End-of-life; Euthanasia; Physician aid-in-dying; Physician-assisted death; Physician-assisted suicide; Slippery slope

Year:  2019        PMID: 30145689     DOI: 10.1007/s11019-018-9864-8

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  2 in total

1.  Rational Suicide in Late Life: A Systematic Review of the Literature.

Authors:  Carla Gramaglia; Raffaella Calati; Patrizia Zeppegno
Journal:  Medicina (Kaunas)       Date:  2019-09-29       Impact factor: 2.430

2.  What passive euthanasia is.

Authors:  Iain Brassington
Journal:  BMC Med Ethics       Date:  2020-05-14       Impact factor: 2.652

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.